相似文献
1
Photodynamic therapy enhancement of anti-tumor immunity.
Photochem Photobiol Sci. 2011 May;10(5):649-52. doi: 10.1039/c0pp00354a. Epub 2011 Jan 21.
2
Enhancement of anti-tumor immunity by photodynamic therapy.
Immunol Res. 2010 Mar;46(1-3):216-26. doi: 10.1007/s12026-009-8119-4.
3
PDT-induced inflammatory and host responses.
Photochem Photobiol Sci. 2011 May;10(5):653-63. doi: 10.1039/c0pp00308e. Epub 2011 Jan 24.
4
Anti-tumor immunity of BAM-SiPc-mediated vascular photodynamic therapy in a BALB/c mouse model.
Cell Mol Immunol. 2017 Feb;14(2):223-234. doi: 10.1038/cmi.2015.84. Epub 2015 Sep 21.
5
CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells.
Br J Cancer. 2007 Jun 18;96(12):1839-48. doi: 10.1038/sj.bjc.6603792. Epub 2007 May 15.
6
Antitumor immunity promoted by vascular occluding therapy: lessons from vascular-targeted photodynamic therapy (VTP).
Photochem Photobiol Sci. 2011 May;10(5):681-8. doi: 10.1039/c0pp00315h. Epub 2011 Jan 24.
7
The immunological consequences of photodynamic treatment of cancer, a literature review.
Immunobiology. 2003;207(2):105-13. doi: 10.1078/0171-2985-00221.
8
Induction of tumor immunity by photodynamic therapy.
J Clin Laser Med Surg. 1996 Oct;14(5):329-34. doi: 10.1089/clm.1996.14.329.
9
Photodynamic therapy and antitumor immunity.
J Natl Compr Canc Netw. 2012 Oct 1;10 Suppl 2(0 2):S40-3. doi: 10.6004/jnccn.2012.0173.
10
Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity.
Apoptosis. 2010 Sep;15(9):1050-71. doi: 10.1007/s10495-010-0479-7.
引用本文的文献
1
Special immune-related adverse events and subsequent photodynamic therapy in tislelizumab treatment for esophageal cancer: a case report.
Front Immunol. 2024 Nov 25;15:1497259. doi: 10.3389/fimmu.2024.1497259. eCollection 2024.
2
Prodrugs of paclitaxel improve in situ photo-vaccination.
Photochem Photobiol. 2024 Oct 9. doi: 10.1111/php.14025.
3
Regulation of inflammation during wound healing: the function of mesenchymal stem cells and strategies for therapeutic enhancement.
Front Pharmacol. 2024 Feb 15;15:1345779. doi: 10.3389/fphar.2024.1345779. eCollection 2024.
4
Folate Receptor Targeted Photodynamic Therapy: A Novel Way to Stimulate Anti-Tumor Immune Response in Intraperitoneal Ovarian Cancer.
Int J Mol Sci. 2023 Jul 10;24(14):11288. doi: 10.3390/ijms241411288.
5
An Efficient 5-Aminolevulinic Acid Photodynamic Therapy Treatment for Human Hepatocellular Carcinoma.
Int J Mol Sci. 2023 Jun 21;24(13):10426. doi: 10.3390/ijms241310426.
6
Photodynamic therapy, priming and optical imaging: Potential co-conspirators in treatment design and optimization - a Thomas Dougherty Award for Excellence in PDT paper.
J Porphyr Phthalocyanines. 2020 Nov-Dec;24(11n12):1320-1360. doi: 10.1142/s1088424620300098.
7
Effect of Hypericin-Mediated Photodynamic Therapy on the Secretion of Soluble TNF Receptors by Oral Cancer Cells.
Pharmaceutics. 2023 Apr 19;15(4):1279. doi: 10.3390/pharmaceutics15041279.
8
Potential of Black Phosphorus in Immune-Based Therapeutic Strategies.
Bioinorg Chem Appl. 2022 Jul 11;2022:3790097. doi: 10.1155/2022/3790097. eCollection 2022.
9
Multifunctional Nanosystems Powered Photodynamic Immunotherapy.
Front Pharmacol. 2022 May 11;13:905078. doi: 10.3389/fphar.2022.905078. eCollection 2022.
10
Photoinduced free radical-releasing systems and their anticancer properties.
Photochem Photobiol Sci. 2022 Aug;21(8):1405-1417. doi: 10.1007/s43630-022-00231-1. Epub 2022 May 13.
本文引用的文献
1
Photodynamic therapy induces interleukin secretion from dendritic cells.
Int J Clin Exp Med. 2010 Apr 25;3(2):110-4.
2
Topical photodynamic therapy is immunosuppressive in humans.
Br J Dermatol. 2010 Mar;162(3):637-41. doi: 10.1111/j.1365-2133.2009.09562.x. Epub 2009 Oct 26.
3
Enhanced systemic immune reactivity to a Basal cell carcinoma associated antigen following photodynamic therapy.
Clin Cancer Res. 2009 Jul 1;15(13):4460-6. doi: 10.1158/1078-0432.CCR-09-0400. Epub 2009 Jun 23.
4
Complement upregulation in photodynamic therapy-treated tumors: Role of Toll-like receptor pathway and NFkappaB.
Cancer Lett. 2009 Aug 28;281(2):232-8. doi: 10.1016/j.canlet.2009.02.049. Epub 2009 Mar 27.
5
Myeloid-derived suppressor cells as regulators of the immune system.
Nat Rev Immunol. 2009 Mar;9(3):162-74. doi: 10.1038/nri2506.
6
Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity.
Cancer Immunol Immunother. 2009 Jan;58(1):71-84. doi: 10.1007/s00262-008-0527-0. Epub 2008 May 17.
7
Immunophototherapy using PDT combined with rapid intratumoral dendritic cell injection.
Photochem Photobiol. 2008 Sep-Oct;84(5):1257-64. doi: 10.1111/j.1751-1097.2008.00356.x. Epub 2008 Apr 23.
8
Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model.
Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5495-500. doi: 10.1073/pnas.0709256105. Epub 2008 Mar 31.
9
The immunosuppressive effects of phthalocyanine photodynamic therapy in mice are mediated by CD4+ and CD8+ T cells and can be adoptively transferred to naive recipients.
Photochem Photobiol. 2008 Mar-Apr;84(2):366-70. doi: 10.1111/j.1751-1097.2007.00270.x. Epub 2008 Jan 15.
10
Photodynamic therapy enhancement of antitumor immunity is regulated by neutrophils.
Cancer Res. 2007 Nov 1;67(21):10501-10. doi: 10.1158/0008-5472.CAN-07-1778.
Zotero 插件